Compare STTK & KEQU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STTK | KEQU |
|---|---|---|
| Founded | 2016 | 1906 |
| Country | United States | United States |
| Employees | N/A | 1239 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.0M | 106.6M |
| IPO Year | 2020 | N/A |
| Metric | STTK | KEQU |
|---|---|---|
| Price | $4.76 | $37.97 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 626.6K | 6.6K |
| Earning Date | 11-06-2025 | 12-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.94 |
| Revenue | $1,000,000.00 | ★ $285,515,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.44 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $0.69 | $30.33 |
| 52 Week High | $4.89 | $71.33 |
| Indicator | STTK | KEQU |
|---|---|---|
| Relative Strength Index (RSI) | 75.73 | 49.44 |
| Support Level | $4.09 | $37.13 |
| Resistance Level | $4.89 | $38.50 |
| Average True Range (ATR) | 0.34 | 0.90 |
| MACD | 0.07 | 0.09 |
| Stochastic Oscillator | 89.50 | 47.62 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.